Product
ketoconazole
Name
Ketoconazole
INN Name
Ketoconazole
FDA Approved
Yes
3 clinical trials
11 organizations
5 indications
1 document
Indication
Prostate CancerIndication
Bone metastasesIndication
Prostate AdenocarcinomaIndication
Recurrent Prostate CancerIndication
NeuroblastomaClinical trial
Phase II Randomized Study of High-Dose Ketoconazole With or Without Alendronate Sodium in Patients With Androgen-Independent Metastastic Adenocarinoma of the ProstateStatus: Terminated
Clinical trial
A Phase III Randomized Trial for Evaluating Second Line Hormonal Therapy (Ketoconazole/Hydrocortisone) Versus Paclitaxel/Estramustine Combination Chemotherapy on Progression Free Survival in Asymptomatic Patients With a Rising PSA After Hormonal Therapy for Prostate CancerStatus: , Estimated PCD: 2004-12-01
Clinical trial
Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder in Patients With Recurrent or Resistant NeuroblastomaStatus: Completed, Estimated PCD: 2014-03-01
Document
DailyMed Label: KetoconazoleOrganization
Rebel Distributors Corp.Organization
A-S Medication SolutionsOrganization
Physicians Total Care, Inc.Organization
Encube Ethicals Private LimitedOrganization
Teva Pharmaceuticals USA, Inc.Organization
NuCare Pharmaceuticals,Inc.Organization
STAT RX USA LLCOrganization
DIRECT RXOrganization
Padagis Israel Pharmaceuticals LtdOrganization
Thirty Madison IncOrganization
Preferred Pharmaceuticals, Inc.